AJIC: American Journal of Infection Control
Volume 37, Issue 9 , Pages 746-752 , November 2009

A prospective study of the impact of colonization following hospital admission by glycopeptide-resistant Enterococci on mortality during a hospital outbreak

  • Alexis Hautemanière, MD, PhD

      Affiliations

    • Centre Hospitalier Universitaire de Nancy, Vandoeuvre les Nancy, France
    • Nancy Université, Vandoeuvre les Nancy, France
    • Inserm Eri 11, Vandoeuvre les Nancy, France
    • Corresponding Author InformationAddress correspondence to A. Hautemanière MD, PhD, professor associate, Département Environnement et Santé Publique-S.E.R.E.S., Faculté de Médecine, 9 Avenue de la Forêt de Haye, B.P. 184, 54505 Vandoeuvre-les-Nancy, France.
    • ,
  • Paul R. Hunter, MD, PhD

      Affiliations

    • Nancy Université, Vandoeuvre les Nancy, France
    • School of Medicine, Health Policy and Practice University of East Anglia, Norwich, England
    • ,
  • Nathalie Diguio, MD

      Affiliations

    • Centre Hospitalier Universitaire de Nancy, Vandoeuvre les Nancy, France
    • ,
  • Elaine Albuisson, MD, PhD

      Affiliations

    • Centre Hospitalier Universitaire de Nancy, Vandoeuvre les Nancy, France
    • Nancy Université, Vandoeuvre les Nancy, France
    • ,
  • Philippe Hartemann, MD, PhD

      Affiliations

    • Centre Hospitalier Universitaire de Nancy, Vandoeuvre les Nancy, France
    • Nancy Université, Vandoeuvre les Nancy, France
    • Inserm Eri 11, Vandoeuvre les Nancy, France

References 

  1. Cookson BD, Macrae MB, Barrett SP, Brown DF, Chadwick C, French GL, et al. Guidelines for the control of glycopeptide-resistant enterococci in hospitals. J Hosp Infect. 2006;62:6–21
  2. Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Eng J Med. 1988;319:157–161
  3. Noble WC, Virani Z, Cree RG. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett. 1992;93:195–198
  4. Howden BP. Recognition and management of infections caused by vancomycin-intermediate Staphylococcus aureus (VISA) and heterogenous VISA. (h VISA). Intern Med J. 2005;35:S136–S140
  5. Centers for Disease Control and Prevention (CDC) . Staphylococcus aureus resistant to vancomycin, United States 2002. MMWR Morb Mortal Wkly Rep. 2002;51:565–567
  6. Tenover FC, Weigel LM, Appelbaum PC, McDougal LK, Chaitram J, McAlister S, et al. Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania. Antimicrob Agents Chemother. 2004;48:275–280
  7. Centers for Disease Control and Prevention (CDC) . Vancomycin-resistant Staphylococcus aureus—Pennsylvania, 2002. MMWR Morb Mortal Wkly Rep. 2002;51:902
  8. Weigel LM, Clewell DB, Gill SR, Clark NC, McDougal LK, Flannagan SE, et al. Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science. 2003;302:1569–1571
  9. Whitener CJ, Park SY, Browne FA, Parent LJ, Julian K, Bozdogan B, et al. Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure. Clin Infect Dis. 2004;38:1056–1057
  10. Tiwari HK, Sen MR. Emergence of vancomycin-resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India. BMC Infect Dis. 2006;6:156
  11. Centers for Disease Control and Prevention. Methicillin (oxacillin)-resistant Staphylococcus aureus (MRSA) among ICU patients, 1995-2004. Available from: http://www.cdc.gov/ncidod/dhqp/pdf/ar/ICU_RESTrend1995-2004.pdf. Accessed October 3, 2007.
  12. Chavers LS, Moser SA, Funkhouser E, Benjamin WH, Chavers P, Stamm AM, et al. Association between antecedent intravenous antimicrobial exposure and isolation of vancomycin-resistant enterococci. Microb Drug Resist. 2003;9:S69–S77
  13. Carmeli Y, Samore MH, Huskins C. The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci: a meta-analysis. Arch Intern Med. 1999;159:2461–2468
  14. Patel R. Clinical impact of vancomycin-resistant enterococci. J Antimicrob Chemother. 2003;51(suppl 3):iii13-21
  15. Weinstein JW, Roe M, Towns M, Sanders L, Thorpe JJ, Corey GR, et al. Resistant enterococci: a prospective study of prevalence, incidence, and factors associated with colonization in a university hospital. Infect Control Hosp Epidemiol. 1996;17:36–41
  16. Montecalvo MA, Jarvis WR, Uman J, Shay DK, Petrullo C, Rodney K, et al. Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting. Ann Intern Med. 1999;131:269–272
  17. Zervos MJ, Kauffman CA, Therasse PM, Bergman AG, Mikesell TS, Schaberg DR. Nosocomial infection by gentamicin-resistant Streptococcus faecalis: an epidemiologic study. Ann Intern Med. 1987;106:687–691
  18. Boisivon A, Thibault M, Leclercq R, Farrington M, Fry C, Humphreys H, et al. Colonization by vancomycin-resistant enterococci of the intestinal tract of patients in intensive care units from French general hospitals. Clin Microbiol Infect. 1997;3:175–179
  19. Metallidis S, Chatzidimitriou M, Tsona A, Bisiklis A, Lazaraki G, Koumentaki E, et al. Vancomycin-resistant enterococci, colonizing the intestinal tract of patients in a university hospital in Greece. Braz J Infect Dis. 2006;10:179–184
  20. Cetinkaya Y, Falk P, Mayhall CG. Vancomycin-resistant enterococci. Clin Microbiol Rev. 2000;13:686–707
  21. Wendt C, Wiesenthal B, Dietz E, Ruden H. Survival of vancomycin-resistant and vancomycin-susceptible enterococci on dry surfaces. J Clin Microbiol. 1998;36:3734–3736
  22. Coia JE, Duckworth GJ, Edwards DI, et al. Collége de Bactériologie-Virologie-Hygiène des Hôpitaux Généraux Français. Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect. 2006;63:S1–44
  23. Shay DK, Maloney SA, Montecalvo M, Banerjee S, Wormser GP, Arduino MJ, et al. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis. 1995;172:993–1000
  24. Orloff SL, Busch AM, Olyaei AJ, Corless CL, Benner KG, Flora KD, et al. Vancomycin-resistant Enterococcus in liver transplant patients. Am J Surg. 1999;177:418–422
  25. Mascini EM, Jalink KP, Kamp-Hopmans TE, Blok HE, Verhoef J, Bonten MJ, et al. Acquisition and duration of vancomycin-resistant enterococcal carriage in relation to strain type. J Clin Microbiol. 2003;41:5377–5383
  26. Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis. 2003;36:131–139
  27. Avery R, Kalaycio M, Pohlman B, Sobecks R, Kuczkowski E, Andersen S, et al. Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course. Bone Marrow Transplant. 2005;35:497–499
  28. Dubberke ER, Hollands JM, Georgantopoulos P, McDougal LK, Chaitram J, McAlister S, et al. Vancomycin-resistant enterococcal bloodstream infections on a hematopoietic stem cell transplant unit: are the sick getting sicker?. Bone Marrow Transplant. 2006;38:813–819
  29. Wynn BO, Beckett M, Hillborne L, Scott M, Bahney B. Evaluation of severity-adjusted DRG systems: interim report. Rand Health Working Paper WR-434-CMS 2007. Available from: www.cms.hhs.gov/Reports/downloads/Wynn0307.pdf: Accessed January 30, 2009.
  30. Bellanger MM, Laurent Tardif L. Accounting and reimbursement schemes for inpatient care in France. Health Care Manag Sci. 2006;9:295–305
  31. ATIH. Guide methodologique de production des résumés de séjours du PMSI en Médecine, Chirurgie et Obstétrique. Available from: http://www.atih.sante.fr/index.php?id=000240006FFF: Accesssed February 2, 2009.
  32. Schneeweiss S, Maclure M. Use of comorbidity scores for control of confounding in studies using administrative databases. Int J Epidemiol 200;29:891–898.
  33. Kirkwood BR, Sterne JAC. Essential medical statistics. 2nd edition. Blackwell Science, Oxford; 2003;
  34. McNeil SA, Malani PN, Chenoweth CE, Fontana RJ, Magee JC, Punch JD, et al. Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients: a prospective surveillance study. Clin Infect Dis. 2006;42:195–203
  35. Roghmann MC, Fink JC, Polish L, Maker T, Brewrink J, Morris JG, et al. Colonization with vancomycin-resistant enterococci in chronic hemodialysis patients. Am J Kidney Dis. 1998;32:254–257
  36. Chan YH. Biostatistics 203. Survival analysis. Singapore Med J. 2004;45:249–256
  37. Blot S, Depuydt P, Vandewoude K, De Bacquer D. Measuring the impact of multidrug resistance in nosocomial infection. Curr Opin Infect Dis. 2007;20:391–396

 Conflicts of interest: None to report.

PII: S0196-6553(09)00424-6

doi: 10.1016/j.ajic.2009.02.007

AJIC: American Journal of Infection Control
Volume 37, Issue 9 , Pages 746-752 , November 2009

Article Tools

* Image Usage & Resolution